405 related articles for article (PubMed ID: 15596110)
1. Tetrahydrobiopterin: regulator of endothelial nitric oxide synthase in vascular disease.
Channon KM
Trends Cardiovasc Med; 2004 Nov; 14(8):323-7. PubMed ID: 15596110
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of superoxide production in human blood vessels: relationship to endothelial dysfunction, clinical and genetic risk factors.
Channon KM; Guzik TJ
J Physiol Pharmacol; 2002 Dec; 53(4 Pt 1):515-24. PubMed ID: 12512689
[TBL] [Abstract][Full Text] [Related]
4. Dysfunction of endothelial nitric oxide synthase and atherosclerosis.
Kawashima S; Yokoyama M
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):998-1005. PubMed ID: 15001455
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease.
Schmidt TS; Alp NJ
Clin Sci (Lond); 2007 Jul; 113(2):47-63. PubMed ID: 17555404
[TBL] [Abstract][Full Text] [Related]
6. Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice.
Alp NJ; McAteer MA; Khoo J; Choudhury RP; Channon KM
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):445-50. PubMed ID: 14707037
[TBL] [Abstract][Full Text] [Related]
7. Augmented BH4 by gene transfer restores nitric oxide synthase function in hyperglycemic human endothelial cells.
Cai S; Khoo J; Channon KM
Cardiovasc Res; 2005 Mar; 65(4):823-31. PubMed ID: 15721862
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of tetrahydrobiopterin for treating vascular and cardiac disease.
Moens AL; Kass DA
J Cardiovasc Pharmacol; 2007 Sep; 50(3):238-46. PubMed ID: 17878750
[TBL] [Abstract][Full Text] [Related]
9. Oxygen radical stress in vascular disease: the role of endothelial nitric oxide synthase.
Stroes ES; van Faassen EE; van Londen GJ; Rabelink TJ
J Cardiovasc Pharmacol; 1998; 32 Suppl 3():S14-21. PubMed ID: 9883742
[TBL] [Abstract][Full Text] [Related]
10. Endothelial nitric oxide synthase in vascular disease: from marvel to menace.
Förstermann U; Münzel T
Circulation; 2006 Apr; 113(13):1708-14. PubMed ID: 16585403
[TBL] [Abstract][Full Text] [Related]
11. Tetrahydrobiopterin and endothelial function.
Cosentino F; Lüscher TF
Eur Heart J; 1998 Jul; 19 Suppl G():G3-8. PubMed ID: 9717048
[TBL] [Abstract][Full Text] [Related]
12. Reduced vascular NO bioavailability in diabetes increases platelet activation in vivo.
Schäfer A; Alp NJ; Cai S; Lygate CA; Neubauer S; Eigenthaler M; Bauersachs J; Channon KM
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1720-6. PubMed ID: 15242858
[TBL] [Abstract][Full Text] [Related]
13. Tetrahydrobiopterin: mediator of endothelial protection.
Katusic ZS; d'Uscio LV
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):397-8. PubMed ID: 15003973
[No Abstract] [Full Text] [Related]
14. The eNOS cofactor tetrahydrobiopterin improves endothelial dysfunction in livers of rats with CCl4 cirrhosis.
Matei V; Rodríguez-Vilarrupla A; Deulofeu R; Colomer D; Fernández M; Bosch J; Garcia-Pagán JC
Hepatology; 2006 Jul; 44(1):44-52. PubMed ID: 16799985
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide and vascular insulin resistance.
Wu G; Meininger CJ
Biofactors; 2009; 35(1):21-7. PubMed ID: 19319842
[TBL] [Abstract][Full Text] [Related]
16. Tetrahydrobiopterin: pleiotropic roles in cardiovascular pathophysiology.
Cunnington C; Channon KM
Heart; 2010 Dec; 96(23):1872-7. PubMed ID: 20837663
[TBL] [Abstract][Full Text] [Related]
17. Tetrahydrobiopterin prevents endothelial dysfunction and restores adiponectin levels in rats.
Wang X; Hattori Y; Satoh H; Iwata C; Banba N; Monden T; Uchida K; Kamikawa Y; Kasai K
Eur J Pharmacol; 2007 Jan; 555(1):48-53. PubMed ID: 17098227
[TBL] [Abstract][Full Text] [Related]
18. (6R)-5,6,7,8-tetrahydro-L-biopterin and its stereoisomer prevent ischemia reperfusion injury in human forearm.
Mayahi L; Heales S; Owen D; Casas JP; Harris J; MacAllister RJ; Hingorani AD
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1334-9. PubMed ID: 17413035
[TBL] [Abstract][Full Text] [Related]
19. Augmentation of vascular remodeling by uncoupled endothelial nitric oxide synthase in a mouse model of diabetes mellitus.
Sasaki N; Yamashita T; Takaya T; Shinohara M; Shiraki R; Takeda M; Emoto N; Fukatsu A; Hayashi T; Ikemoto K; Nomura T; Yokoyama M; Hirata K; Kawashima S
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1068-76. PubMed ID: 18403727
[TBL] [Abstract][Full Text] [Related]
20. Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease.
Alp NJ; Channon KM
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):413-20. PubMed ID: 14656731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
